Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment - Sean Wharton; Louis J. Aronne; Adam Stefanski; Nasreen F. Alfaris; Andreea Ciudin; Koutaro Yokote; Bruno Halpern; Alpana P. Shukla; Chunmei Zhou; Lisa Macpherson; Sheryl E. Allen; Nadia N. Ahmad; et al. (New England Journal of Medicine, 2025)